CANX binds EBI3

Stable Identifier
Reaction [binding]
Homo sapiens
Interleukin-27 subunit beta binds Calnexin
Locations in the PathwayBrowser
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout

Calnexin (CANX or p95 calnexin) binds Interleukin-27 subunit beta (EBI3, IL27B). In human cell lines (BL30, BL41, Louckes, BJAB, P3HR1) most newly synthesized EBI3 is retained in the endoplasmic reticulum (ER) in an endoglycosidase H-sensitive form (Devergne et al. 1996, 1997), bound to CANX and a 60-kDa protein and transiently with a p75-kDa protein, both ignored here). EBI3 can be released by itself but the association with CANX prevents this, the complex is retained in the ER. The co-expression of other interleukin subunits enables the release of EBI3 in a complex with Interleukin-27 subunit alpha (IL27) (Devergne et al. 1996).

Literature References
PubMed ID Title Journal Year
9342359 Epstein-Barr virus-induced gene 3 and the p35 subunit of interleukin 12 form a novel heterodimeric hematopoietin

Birkenbach, M, Devergne, O, Kieff, E

Proc. Natl. Acad. Sci. U.S.A. 1997
8483502 A novel dimer configuration revealed by the crystal structure at 2.4 A resolution of human interleukin-5

Hassell, AM, Milburn, MV, Proudfoot, AE, Wells, TN, Graber, P, Jordan, SR, Lambert, MH

Nature 1993
Orthologous Events
Cite Us!